-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Meridian Bioscience Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q4 2010 to Q4 2022.
- Meridian Bioscience Inc Deferred Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $216K, a 76.7% decline year-over-year.
- Meridian Bioscience Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.1M, a 71.3% increase from 2021.
- Meridian Bioscience Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$3.84M, a 605% decline from 2020.
- Meridian Bioscience Inc annual Deferred Income Tax Expense (Benefit) for 2020 was $760K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)